NIPT - Non-Invasive-Prenatal-Test for trisomies
The risk of having a child with a chromosomal anomaly is small. The basic risk depends on your age.
A Combined Test provides you with further information how low or how high this risk really is. It can detect over 90% of all trisomies, some other chromosomal anomalies and the majority of severe fetal anomalies.
However, the issue of trisomy 21 is of special interest for many families, since it is not only the most common chromosomal anomaly, but also because people with trisomy 21 have a close to normal life expectancy. Also pregnancy ultrasound can not identify all affected fetuses.
Since 2012 there are a number of special test available which can examine the small fraction of fetal DNA found in the maternal blood. These test
are called Non Invasive Prenatal Test (NIPT - also known as Cell-free-fetal DNA testing) and can identify
over 99% fetuses affected by trisomy 21, over 96% of fetuses with trisomy 18, and 92% of fetuses with trisomy 13. This test only identifies the most common
trisomies, but no other developmental anomalies.
Without a detailed ultrasound such as the Combined Test or the Organscreening (Anomaly scan) NIPT does not pick up fetal developmental anomalies.
At a maternal weight of less than 90 kg it is mostly possible to achieve a test result (in 99,5%). The success rate of the test falls with increasing maternal weight. A free retake mostly succeeds to provide a result even in these cases.
In rare cases the test gives a false positive result for trisomies even if the fetus is not affected. This happens in less than 1 in 1000 pregnancies. In case of a positive test (signs of a trisomy) an invasive test will be offered, as only such a test can give you 100% certainty.
The results of the test are available mostly within 14 days (mostly within 8-10 workdays).
Both you and your gynaecologist will be informed immediately upon receiving the test results.